Skip to main content
. 2010 Jan 21;5(1):e8802. doi: 10.1371/journal.pone.0008802

Figure 3. Overview of the resultsobtained by the mutation assays (A) and by sequence analysis (B) in 294 tumor DNA samples from patients with advanced colorectal cancer.

Figure 3